Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Hong-Lee Yu who wrote (752)	9/25/1998 3:16:00 PM
From: Harold Engstrom	Respond to of 1686

Hong-Lee Yu, I think the 2ndary progressive is close to the same size as remitting-relapsing indication. Will have to look back and check that out again. Biogen indicated that 2000 lauch into that market would be roughly equivalent to initial Avonex launch. Also, I think the company expected a second product out in 2001, and maybe will have two out in that time frame. Agree that 25% growth beyond 1999 is more than achievable AND that growth rate through 1999 may be more spectacular than currently conceived.